Doctors are exploring an old, affordable diabetes drug as a possible way to help prevent dementia using real-world data from ...

New research in Diabetes, Obesity and Metabolism reveals that metformin, a medication traditionally prescribed to treat ...

New research in Diabetes, Obesity and Metabolism reveals that metformin, a medication traditionally prescribed to treat ...

If you’re struggling with weight, you’re not alone. Around 42 percent of American adults have obesity. In addition to ...

Results confirm previous findings that nonarteritic anterior ischemic optic neuropathy (NAION) was more likely in those who used semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA).

The Microdose GLP-1Rx Program will offer low-dose GLP-1 prescriptions combined with behavioral coaching, clinical monitoring and medication management.

HealthDay News — For older adults with type 2 diabetes, glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with the risk of developing nonarteritic anterior ischemic optic ...

Customers that use Giant Eagle Pharmacy now have the opportunity to see big savings on their medications though a partnership ...

Research on Alzheimer's risk factors shows significant sex differences, with implications for diagnosis and treatment in ...